Overexpression of Bcl-2 protein has been known to play a role in the pathogenesis of follicular lymphoma (FL). However, 10-15% of FLs are negative for Bcl-2 by immunohistochemistry, raising the possibility that another gene product(s) may provide prosurvival signal(s). We used reverse phase protein microarray to analyze lysates of follicle center cells isolated by laser capture microdissection from: Bcl-2 + FL, Bcl-2 - FL and reactive follicular hyperplasia (FH) (nine cases each group). TUNEL assay confirmed similar and reduced levels of apoptosis in Bcl-2 + FL and Bcl-2 - FL, indicating the likelihood of Bcl-2-independent inhibition of apoptosis. Arrays were quantitatively analyzed with antibodies to proteins involved in the apoptotic pathway. As expected, Bcl-2 levels were up to eight-fold higher in Bcl-2 + FL than in FH and Bcl-2 - FL. However, there was no difference in levels of Mcl-1 and survivin among these three groups. Bcl-XL showed a trend for increased expression in Bcl-2 - FL as compared with Bcl-2 + FL, although the differences did not reach statistical significance (P>0.1). The increase in Bcl-XL may provide an alternative antiapoptotic signal in FL negative for Bcl-2 protein. Interestingly, Bax expression was higher in FL (Bcl-2 + or -) than in FH (P = 0.001). Notably, phospho-Akt (Ser-473) was increased in FL (Bcl-2 + or -) (P<0.03) with increased phospho-Bad (Ser-136), as compared with levels in FH. The activation of the Akt/Bad pathway provides further evidence of prosurvival signals in FL, independent of Bcl-2 alone. These data suggest that nodal FL represents a single disease with a final common biochemical pathway.
- Follicular lymphoma
- Protein microarray